全球癌症登記系統軟體市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計癌症登記軟體市場將從 2025 年的 1.0218 億美元成長到 2034 年的 3.0305 億美元，2026 年至 2034 年的複合年成長率為 12.84%。

由於癌症發病率不斷上升以及醫療保健行業對高效數據管理系統的需求日益成長，全球癌症登記軟體市場正經歷顯著成長。癌症登記軟體幫助醫療機構收集、儲存和分析病患數據，以便更好地監測和研究疾病。各國政府和醫療機構正擴大採用這些系統來追蹤癌症發生率並改善治療方案。

人們對醫療數據分析和數位健康解決方案日益成長的興趣進一步推動了市場需求。癌症登記軟體有助於提高流行病學研究的質量，支持臨床決策，並識別癌症病例趨勢。此外，對醫療保健IT基礎設施的投入增加以及政府為促進癌症監測計畫所採取的措施也促進了市場成長。

未來幾年，人工智慧 (AI) 和雲端技術的融合有望提升癌症登記系統的功能。這些進步將提高數據的準確性、可訪問性和即時分析能力。全球對癌症研究、早期檢測和公共衛生管理的日益關注，將繼續為該市場帶來強勁的成長機會。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球癌症登記系統軟體市場：依軟體類型分類

• 市場分析、洞察與預測
• 獨立版
• 融合的

第5章 全球癌症登記系統軟體市場：依部署模式分類

• 市場分析、洞察與預測
• 現場
• 基於雲端的

第6章 全球癌症登記系統軟體市場：按組件分類

• 市場分析、洞察與預測
• 商業的
• 一般的

第7章 全球癌症登記系統軟體市場：依最終用途分類

• 市場分析、洞察與預測
• 政府和第三方
• 私人保險公司
• 醫院和診所
• 製藥、生技和醫療設備公司
• 研究機構

第8章 全球癌症登記系統軟體市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Elekta AB
  • Oracle Corporation
  • ONCO Inc
  • International Business Machines Corporation（IBM）
  • McKesson Corporation
  • Conduent Incorporated
  • Ordinate Corporation
  • Volpara Health Technologies Limited
  • Health Catalyst Inc
  • Rocky Mountain Cancer Data Systems（University Of Utah Health）

The Cancer Registry Software Market size is expected to reach USD 303.05 Million in 2034 from USD 102.18 Million (2025) growing at a CAGR of 12.84% during 2026-2034.

The global cancer registry software market is witnessing notable growth due to the increasing prevalence of cancer and the need for efficient data management systems in healthcare. Cancer registry software helps healthcare organizations collect, store, and analyze patient data for better disease monitoring and research. Governments and healthcare institutions are increasingly adopting such systems to track cancer incidence and improve treatment planning.

The growing emphasis on healthcare data analytics and digital health solutions is further driving market demand. Cancer registry software enables better epidemiological research, supports clinical decision-making, and assists in identifying trends in cancer cases. Additionally, rising investments in healthcare IT infrastructure and government initiatives promoting cancer surveillance programs are contributing to market growth.

In the coming years, the integration of artificial intelligence and cloud-based technologies is expected to enhance the capabilities of cancer registry systems. These advancements will improve data accuracy, accessibility, and real-time analysis. Increasing global focus on cancer research, early detection, and population health management will continue to create strong growth opportunities for this market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Software

• Standalone
• Integrated

By Deployment Model

• On-premise
• Cloud Based

By Component

• Commercial
• Public

By End-use

• Government & Third Party
• Private Payers
• Hospital & Medical Practice
• Pharma Biotech & Medical Device Companies
• Research Institutes

COMPANIES PROFILED

• Elekta AB, Oracle Corporation, ONCO Inc, International Business Machines Corporation IBM, McKesson Corporation, Conduent Incorporated, Ordinate Corporation, Volpara Health Technologies Limited, Health Catalyst Inc, Rocky Mountain Cancer Data Systems University of Utah Health
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CANCER REGISTRY SOFTWARE MARKET: BY SOFTWARE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Software
• 4.2. Standalone Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Integrated Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CANCER REGISTRY SOFTWARE MARKET: BY DEPLOYMENT MODEL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Deployment Model
• 5.2. On-premise Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cloud Based Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CANCER REGISTRY SOFTWARE MARKET: BY COMPONENT 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Component
• 6.2. Commercial Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Public Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CANCER REGISTRY SOFTWARE MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Government & Third Party Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Private Payers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Hospital & Medical Practice Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Pharma Biotech & Medical Device Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CANCER REGISTRY SOFTWARE MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Software
  • 8.2.2 By Deployment Model
  • 8.2.3 By Component
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Software
  • 8.3.2 By Deployment Model
  • 8.3.3 By Component
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Software
  • 8.4.2 By Deployment Model
  • 8.4.3 By Component
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Software
  • 8.5.2 By Deployment Model
  • 8.5.3 By Component
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Software
  • 8.6.2 By Deployment Model
  • 8.6.3 By Component
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CANCER REGISTRY SOFTWARE INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Elekta AB
  • 10.2.2 Oracle Corporation
  • 10.2.3 ONCO Inc
  • 10.2.4 International Business Machines Corporation (IBM)
  • 10.2.5 McKesson Corporation
  • 10.2.6 Conduent Incorporated
  • 10.2.7 Ordinate Corporation
  • 10.2.8 Volpara Health Technologies Limited
  • 10.2.9 Health Catalyst Inc
  • 10.2.10 Rocky Mountain Cancer Data Systems (University Of Utah Health)